Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy alone vs. chemotherapy followed by surgery in limited-metastatic gastric or esophagogastric junction adenocarcinoma
2014-002665-30Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Oct 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of docetaxel, oxaliplatin, fluorouracil and folinic acid in gastric adenocarcinoma and gastroesophageal adenocarcinoma (2 arms), sponsored by Krankenhaus Nordwest. Primary endpoint: Overall survival. Started Oct 2015; status: completed.
02
Drugs
docetaxeloxaliplatinfluorouracilfolinic acid
03
Conditions
gastric adenocarcinomagastroesophageal adenocarcinoma
Beyond the preview
Go deeper on 2014-002665-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002665-30.